Alternative Therapies for Menopause: A Randomized Trial
NCT00061711 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 355
Last updated 2009-12-11
Summary
This randomized, controlled trial will evaluate the efficacy and safety of three alternative approaches utilizing phytoestrogens to treat hot flashes and night sweats in peri- and post-menopausal women. The treatments were chosen because of the scientific evidence supporting a possible benefit, the availability of products with adequate quality control, and their frequency of use in naturopathic medicine. RECRUITMENT FOR THIS STUDY SHOULD END BY AUGUST 1, 2003.
Conditions
Interventions
- DRUG
-
Hormone Replacement Therapy
- DRUG
-
Cimicifuga racemosa (Black Cohosh)
- DRUG
-
Multibotanical phytoestrogen formula
Sponsors & Collaborators
-
National Institute on Aging (NIA)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 45 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2000-07-31
- Primary Completion
- 2005-12-31
- Completion
- 2005-12-31
Countries
- United States
Study Locations
More Related Trials
-
Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety
NCT00120458 ·Status: COMPLETED ·Phase: PHASE4
-
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
NCT06186531 ·Status: RECRUITING ·Phase: PHASE2
-
Alternative Treatments for Menopausal Women
NCT02028702 ·Status: COMPLETED ·Phase: NA
-
Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women
NCT06759350 ·Status: COMPLETED ·Phase: NA
-
A Clinical Study Assessing Efficacy of an Herbal Blend on Menopausal Symptoms and Quality of Life
NCT04228757 ·Status: UNKNOWN ·Phase: NA
-
Comparison of the Efficacy and Tolerability of Black Cohosh Vs Tibolone in Patients With Menopausal Symptoms
NCT00299364 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause
NCT05033886 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause
NCT04003155 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Soy Isoflavones on Menopausal Hot Flashes
NCT00179556 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
NCT01723917 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms
NCT02653417 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of MF101 in Postmenopausal Women
NCT00906308 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause
NCT05034042 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes
NCT00119665 ·Status: COMPLETED ·Phase: PHASE2
-
Citalopram in Treating Postmenopausal Women With Hot Flashes
NCT00363909 ·Status: COMPLETED ·Phase: PHASE3
-
Klimadynon® in Comparison to Conjugated Oestrogens in Women Suffering From Menopausal Complaints
NCT02184364 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)
NCT01015677 ·Status: TERMINATED ·Phase: PHASE2
-
FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms
NCT05312567 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Aerobic Exercises With Selected Phytoestrogens on Hot Flushes in Menopausal Women
NCT03434171 ·Status: UNKNOWN ·Phase: NA
-
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
NCT01126801 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause
NCT06206421 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2
NCT04003142 ·Status: COMPLETED ·Phase: PHASE3
-
Soy Estrogen Alternative Study (SEA)
NCT00000612 ·Status: COMPLETED ·Phase: PHASE2
-
QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology
NCT06143696 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
NCT06716554 ·Status: RECRUITING ·Phase: NA